Niagen Bioscience Inc
USD3.49
+0.12 (+3.56%)
CEO
Robert N. Fried
IPO Date
2015-06-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.33
Prev. Close
$3.37
Day Low
$3.33
Day High
$3.50
52W Low
$3.18
52W High
$11.29
Market Cap
$0.28B
Volume
0.62M
| 4,255 |
| $2.71 |
| 8 Jul 2026 | Fried Robert N | director, officer: Chief Executive Officer | A-Award | Acquired | 1,106 | $2.71 |
| 26 Jun 2026 | YU Wing Tak Wendy | director | A-Award | Acquired | 31,746 | $3.45 |
| 26 Jun 2026 | Ng Wang Yu Gary | director | A-Award | Acquired | 31,746 | $3.45 |
| 26 Jun 2026 | Cohen Ann | director | A-Award | Acquired | 31,746 | $3.45 |
| 26 Jun 2026 | Patrick Kristin | director | A-Award | Acquired | 31,746 | $3.45 |
| 26 Jun 2026 | Shahbazi Hamed | director | A-Award | Acquired | 31,746 | $3.45 |
| 26 Jun 2026 | Rubin Steven D | director | A-Award | Acquired | 31,746 | $3.45 |
| 26 Jun 2026 | Jaksch Frank L Jr | director | A-Award | Acquired | 31,746 | $3.45 |